FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
Recommend0 recommendationsPublished in US National Health Agency Sources
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
The Food and Drug Administration (FDA) recently announced its request for $7.2 billion as part of President Joe Biden’s fiscal year (FY) 2025 proposed budget. FDA’s request, which is about 7% higher than last year, covers the agency’s top health priorities. “This funding will allow the agency to enhance food safety and nutrition, advance medical …
The post FDA’s Big Plan to Enhance Public Health in 2025 appeared first on Salud America.
The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Clinicians will learn the FDA’s role in issuing EUAs for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters will also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.
This video can also be viewed at
https://emergency.cdc.gov/coca/wmv/2021/081221_video.mp4
Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. There are four phases of clinical trials that each help scientists answer different questions. Phase 1 clinical trials are the first step in testing a new treatment in people. They focus on evaluating the safety, side effects, …
The post Study: Phase 1 Cancer Treatment Clinical Trials May Offer More Benefits Than in Past appeared first on Salud America.
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
